Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma

Journal of Immunotherapy

Volumn 31, Issue 1, 2008, Pages 72-80

  Fishman, Mayer ^a   Hunter, Terri B ^a   Soliman, Hatem ^a   Thompson, Patricia ^a   Dunn, Mary ^a   Smilee, Renee ^a   Farmelo, Mary Jane ^a   Noyes, David R ^a   Mahany, John J ^b   Lee, Ji Hyun ^a   Cantor, Alan ^a   Messina, Jane ^a   Seigne, John ^c   Pow Sang, Julio ^a   Janssen, William ^a   Antonia, Scott J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b CTRC Institute for Drug Development   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Cancer; Cancer vaccine; Immunotherapy; Interleukin 2; Kidney cancer; Renal cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR CELL VACCINE; CANCER VACCINE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHILL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOTOXICITY; DEEP VEIN THROMBOSIS; DEHYDRATION; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DYSPNEA; EFFUSION; ENZYME LINKED IMMUNOSPOT ASSAY; FATIGUE; FEMALE; HEADACHE; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; HYPONATREMIA; HYPOTENSION; KIDNEY BIOPSY; KIDNEY CARCINOMA; LABORATORY TEST; LEG PAIN; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PAIN; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; T LYMPHOCYTE; TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; KIDNEY TUMOR; LIVER; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; SKIN; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD80; CANCER VACCINES; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; MIDDLE AGED; NEOPLASM STAGING; SKIN; SURVIVAL ANALYSIS; TRANSFECTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 40749088132     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31815ba792     Document Type: Article

References (45)